Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 11.76m | - |
| Gross profit | -16.22m | - |
| Net profit | -26.94m | - |
| EBITDA | -16.22m | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €180.81m |
Number of shares | 49m |
52-week high/low | €7.27 - €2.72 |
| Dividends | No |
Beta | 0.52 |
P/E ratio | -3.00 |
PEG ratio | 0.49 |
P/B ratio | -60.11 |
P/S ratio | 7.59 |
Company profile
Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device that integrates and optimizes the entire medical imaging workflow; and iSee for image analysis services in clinical trials. It also provides imaging contract research services, such as study start up, image and clinical data management, scientific consulting, independent reviews, image data processing and site support, and study close-out for studies. Median Technologies SA has a research collaboration agreement with the University of California. The company was founded in 2002 and is based in Valbonne, France.
| Name | Median Technologies |
| CEO | Fredrik Brag |
| Headquarters | Valbonne,
pac France |
| Website | |
| Sector | Information Technology |
| Industry | Software |
| IPO | 20/05/2011 |
| Employees | 199 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Euronext | ALMDT.PA |
Frankfurt | 4ZG.F |
Düsseldorf | 4ZG.DU |
Paris | ALMDT.PA |
München | 4ZG.MU |
